
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions Corp demonstrates a positive outlook driven by its strong performance in international markets, which supports the resilience of its Crop Protection portfolio despite recent challenges in Argentina. Enhanced momentum in bio-protection products in the U.S. and Latin America, along with rising adjuvant sales in Brazil, has partially mitigated weaker domestic performance. Additionally, management identifies significant international revenue opportunities for its HB4 wheat segment, particularly in the U.S., Brazil, and Australia, positioning the company for future growth as new partnerships are established.
Bears say
Bioceres Crop Solutions has experienced a significant decline in revenue, primarily due to decreased demand for Crop Protection and Crop Nutrition solutions in Argentina, coupled with diminished contributions from its HB4 program following a shift to a licensing-based business model. Specifically, Crop Nutrition revenues dropped approximately 34% year-over-year to around $25 million, driven by softer demand and pricing pressures exacerbated by reduced corn acreage. Additionally, the company's Seed & Integrated products revenues plummeted about 75% year-over-year to approximately $8 million as it exited seed production and focused on technology partnerships.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares